McKesson to Invest $1.4 Billion for 49% Stake in Option Care
McKesson Corporation (NYSE:MCK) is investing roughly $1.4 billion to acquire approximately a 49% stake in Option Care. Under the agreement, private equity firm CD&R will retain a controlling interest of about 51%. The transaction places an enterprise value of approximately $5.8 billion on Option Care.
The strategic partnership aims to broaden patient access to infusion care across home and community settings. By securing this stake, McKesson expands its reach in delivering specialized healthcare services outside traditional hospital settings.
The deal is projected to close in the first half of 2027, contingent on receiving necessary regulatory and shareholder approvals. Shares of McKesson Corporation were up 0.92% to $938.80 following the update.
Key points
- McKesson Corporation is investing about $1.4 billion for a 49% stake in Option Care.
- Option Care is valued at an enterprise value of approximately $5.8 billion in the deal.
- CD&R will hold the remaining 51% controlling interest in Option Care.
- The deal expands infusion care services in community and home settings.
- Completion is expected in H1 2027, pending shareholder and regulatory approvals.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
How much is McKesson investing in Option Care?
McKesson Corporation is investing about $1.4 billion to take a 49% stake in Option Care.
When will the McKesson and Option Care deal close?
The transaction is expected to close in the first half of 2027, subject to regulatory and shareholder approvals.
What is the valuation of Option Care in this transaction?
The deal values Option Care at an enterprise value of approximately $5.8 billion.